The Madison Square Garden Company Names Darren

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
80
The Madison Square Garden Company Names Darren Pfeffer Executive Vice President of MSG Live

NEW YORK, April 11, 2017 (GLOBE NEWSWIRE) -- The Madison Square Garden Company (NYSE: MSG ) today announced that Darren Pfeffer has been named executive vice president of MSG Live, effective May 17.  Mr. Pfeffer joins the company after spending the last two decades at iHeartMedia, a leading media and entertainment company, where he most recently served as senior vice president of Music and Entertainment Marketing.

In this newly-created role, Mr. Pfeffer will oversee MSG’s live entertainment events – including concerts, family shows, performing arts and special events – that are presented or hosted in the Company’s diverse collection of venues. Those venues are: Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, the Beacon Theatre, the Forum, The Chicago Theatre and the Wang Theatre. MSG also produces outdoor festivals through Boston Calling Events, the entertainment production company responsible for New England’s premier music festival – Boston Calling. With the overarching goal of maximizing the utilization of the company’s venues and delivering top tier talent, Mr. Pfeffer will be responsible for setting the strategic direction for MSG’s bookings, which includes exploring opportunities to develop new signature events, artist residencies and unique experiences for MSG’s customers.  In addition, he will play a key role in the future success of MSG’s venue expansion strategy, including the company’s plans to build a groundbreaking new venue in Las Vegas.  Other priorities will consist of daily oversight of financial and operational matters; identifying and building key strategic relationships; and working with colleagues across the company to create marketing and sales plans.  Mr. Pfeffer will report to MSG’s president and chief executive officer, David O’Connor.

“Darren has spent more than 20 years in entertainment, overseeing some of the industry’s most popular events and creating opportunities to leverage talent.  His relationships, along with his experience developing compelling programming, will serve us well as we remain focused on growing our live event business by exploring new and better ways to utilize our world-class portfolio of venues,” said Mr. O’Connor.  “We look forward to having him as part of our leadership team as we continue to build on MSG’s outstanding tradition of delivering unique and exceptional live experiences.”

“The Madison Square Garden Company is peerless in its portfolio of iconic venues, world-class partners and access to top-tier performers and events,” said Mr. Pfeffer.  “I am thrilled to join the team, and look forward to not only continuing to grow the live event business, but to providing unforgettable experiences for MSG’s customers and partners.” 

Mr. Pfeffer joins MSG after more than 20 years with iHeartMedia, where he has held a number of positions with increasing responsibility.  Most recently, as senior vice president of Music and Entertainment Marketing, Mr. Pfeffer was responsible for overseeing all aspects of more than 160 iHeartMedia events including: overall event strategy, operations, and sponsorship and partnership opportunities, as well as any production and broadcast elements.  These high-profile events include: the iHeartRadio Music Festival in Las Vegas, the iHeartCountry Festival and the iHeartRadio Fiesta Latina. Mr. Pfeffer has also served as executive producer of Z100’s Jingle Ball since 2006 – turning the annual holiday concert into an iconic New York City event that is nationally televised on The CW Network – and oversaw the multi-market iHeartRadio Jingle Ball Tour, which includes stops in Los Angeles, Boston, Chicago and Miami.

In addition to delivering exceptional live experiences for consumers, Mr. Pfeffer spearheaded iHeartMedia's B2B event strategy, producing a number of industry events at shows throughout the world, including CES, Cannes Lions, SXSW and AdWeek. He also worked directly with iHeartMedia's marketing partners to create innovative event integrations and promotions for brands such as Target, Pepsi, State Farm, Chase, Verizon and Macy's.  Mr. Pfeffer started at iHeartMedia as an intern in 1995. 

About The Madison Square Garden Company The Madison Square Garden Company (MSG) is a world leader in live sports and entertainment experiences.  The company presents or hosts a broad array of premier events in its diverse collection of iconic venues: New York’s Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall and Beacon Theatre; the Forum in Inglewood, CA; The Chicago Theatre; and the Wang Theatre in Boston.  Other MSG properties include legendary sports franchises: the New York Knicks (NBA), the New York Rangers (NHL) and the New York Liberty (WNBA), along with two development league teams -- the Westchester Knicks (NBADL) and the Hartford Wolf Pack (AHL).  In addition, the Company features popular original entertainment productions -- the Christmas Spectacular and New York Spectacular – both starring the Radio City Rockettes, and through Boston Calling Events, produces outdoor festivals, including New England’s preeminent Boston Calling Music Festival.   Also under the MSG umbrella is TAO Group, a world-class hospitality group with globally-recognized entertainment dining and nightlife brands: Tao, Marquee, Lavo, Avenue, The Stanton Social, Beauty & Essex and Vandal.  More information is available at  www.themadisonsquaregardencompany.com

Contact: Mikyl Cordova / Mikyl.Cordova@msg.com / 212-631-4337

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading